TY - JOUR
T1 - Sulfonylurea treatment in a girl with neonatal diabetes (KCNJ11 R201H) and celiac disease
T2 - Impact of low compliance to the gluten free diet
AU - Delvecchio, Maurizio
AU - Zecchino, Clara
AU - Faienza, Maria Felicia
AU - Acquafredda, Angelo
AU - Barbetti, Fabrizio
AU - Cavallo, Luciano
PY - 2009/6
Y1 - 2009/6
N2 - A girl with celiac disease and KCNJ11 mutation was transferred to glibenclamide when 19.8 years old. When her compliance to the gluten free diet worsened, her metabolic control deteriorated. Since glibenclamide is absorbed in the intestine, its absorption seems to be impaired by chronic malabsorption, increasing the risk of hyperglycaemia.
AB - A girl with celiac disease and KCNJ11 mutation was transferred to glibenclamide when 19.8 years old. When her compliance to the gluten free diet worsened, her metabolic control deteriorated. Since glibenclamide is absorbed in the intestine, its absorption seems to be impaired by chronic malabsorption, increasing the risk of hyperglycaemia.
KW - Celiac disease
KW - Gluten free diet
KW - KCNJ11
KW - Neonatal diabetes
KW - Sulfonylurea
UR - http://www.scopus.com/inward/record.url?scp=67349171387&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67349171387&partnerID=8YFLogxK
U2 - 10.1016/j.diabres.2009.02.024
DO - 10.1016/j.diabres.2009.02.024
M3 - Article
C2 - 19345438
AN - SCOPUS:67349171387
VL - 84
SP - 332
EP - 334
JO - Diabetes Research and Clinical Practice
JF - Diabetes Research and Clinical Practice
SN - 0168-8227
IS - 3
ER -